Muscle Stress Relief An integrated research program linking together basic rese...
Muscle Stress Relief An integrated research program linking together basic research on secondary myopathies in stress states to innovative translation in applied myology.
A diverse variety of medical or lifestyle conditions lead to a progressive loss of muscle force by functionally impairing myofibril contractility and causing ultimately myofibril loss. Major underlying risk factors of chronic musc...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
MYOAGE
Understanding and combating human age related muscle weaknes...
15M€
Cerrado
AmyloAge
AmyloAge balancing proteostasis and metabolism in age relat...
203K€
Cerrado
REBUILD
Mechanisms of sarcomeric protein homeostasis during physical...
185K€
Cerrado
REALISM
Reducing Early Atrophy with Leucine during Immobilization of...
178K€
Cerrado
PID2019-108202RA-I00
REVERTIR LA MOVILIDAD REDUCIDA EN PERSONAS FRAGILES MAYORES...
45K€
Cerrado
Myo_LysoZOOM
An insight into lysosomal signature in muscle wasting
269K€
Cerrado
Información proyecto Muscle stress relief
Duración del proyecto: 62 meses
Fecha Inicio: 2014-12-03
Fecha Fin: 2020-02-29
Líder del proyecto
PANEPISTIMIO THESSALIAS
No se ha especificado una descripción o un objeto social para esta compañía.
TRL
4-5
Presupuesto del proyecto
2M€
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
A diverse variety of medical or lifestyle conditions lead to a progressive loss of muscle force by functionally impairing myofibril contractility and causing ultimately myofibril loss. Major underlying risk factors of chronic muscle force loss are ageing, inactive lifestyles, and unbalanced nutrition. Together, these factors are predicted to lead to an endemic incidence of muscle weakness both in the developed countries. Clinical research on the mechanisms involved requires a multidisciplinary approach covering aspects of ageing, metabolism, and on the humoral cross-talk of muscle with other key organs including heart, liver, kidney, and lung. To achieve this, six European groups with complementary expertise in inter-organ-cross-talk during stress-induced secondary myopathies will team-up with three leading teams in the U.S. with expertise in myopathy animal models, myofilament proteins and translation of muscle research into therapeutic interventions, and with one team from South Africa with cutting-edge expertise in the regulation of regenerative capacities in muscle.
Importantly, five SMEs will participate in this RISE network that provide expertise in early muscle disease detection, monitoring, and the developing preventive strategies: Their knowledge on muscle disease detection at early stages and their monitoring during interventions will promote translational innovation. To implement innovation and our joint research program, both early stage and advanced researchers will be seconded from the academic nine teams to these five SMEs and vice versa. Thereby, this RISE scheme will establish a long-term collaborative University-SME driven translational innovative research program innovation in our interdisciplinary field of growing socioeconomic medical importance.